The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.
As a result of participation in this activity, participants will be able to:
- Discuss the clinical profile of heart failure and differentiate types of heart failure based on state of patient’s left ventricular ejection fraction: reduced, preserved, or mid-range
- Apply appropriate strategies to optimize use of current and novel drug therapy of heart failure with reduced left ventricular ejection fraction
- Understand the latest findings concerning pharmacological approaches to heart failure with mid-range or preserved ejection fraction
- Evaluate patients for advanced surgical therapies for heart failure including left ventricular assist device and cardiac transplantation, as well as interventional approaches like transcatheter mitral valve replacement and ambulatory hemodynamic monitoring
- Understand options for electrophysiological interventions to address risk of sudden death and atrial arrhythmias in patients with heart failure
This course is designed for Cardiologists, Family Medicine Physicians, General Internists, Nurses and Nurse Practitioners, Physician Assistants, Pharmacists, Hospitalists and Cardiology Technicians.
Course faculty will present information in a case discussion and lecture format. There will be opportunities for the audience to ask questions in a panel discussion setting.
University of Florida College of Medicine adheres to the ACCME Standards regarding commercial support of continuing medical education. It is policy that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this education activity, that relevant conflicts of interest are resolved, and that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.